1. Home
  2. MAIN vs CYTK Comparison

MAIN vs CYTK Comparison

Compare MAIN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAIN
  • CYTK
  • Stock Information
  • Founded
  • MAIN 2007
  • CYTK 1997
  • Country
  • MAIN United States
  • CYTK United States
  • Employees
  • MAIN N/A
  • CYTK N/A
  • Industry
  • MAIN Finance/Investors Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAIN Finance
  • CYTK Health Care
  • Exchange
  • MAIN Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • MAIN 5.2B
  • CYTK 5.0B
  • IPO Year
  • MAIN 2007
  • CYTK 2004
  • Fundamental
  • Price
  • MAIN $62.26
  • CYTK $50.26
  • Analyst Decision
  • MAIN Hold
  • CYTK Strong Buy
  • Analyst Count
  • MAIN 5
  • CYTK 17
  • Target Price
  • MAIN $48.80
  • CYTK $82.00
  • AVG Volume (30 Days)
  • MAIN 479.2K
  • CYTK 1.9M
  • Earning Date
  • MAIN 02-27-2025
  • CYTK 02-27-2025
  • Dividend Yield
  • MAIN 6.17%
  • CYTK N/A
  • EPS Growth
  • MAIN 11.78
  • CYTK N/A
  • EPS
  • MAIN 5.51
  • CYTK N/A
  • Revenue
  • MAIN $529,897,000.00
  • CYTK $3,219,000.00
  • Revenue This Year
  • MAIN $10.58
  • CYTK N/A
  • Revenue Next Year
  • MAIN $5.22
  • CYTK $754.18
  • P/E Ratio
  • MAIN $11.30
  • CYTK N/A
  • Revenue Growth
  • MAIN 9.27
  • CYTK N/A
  • 52 Week Low
  • MAIN $44.92
  • CYTK $40.53
  • 52 Week High
  • MAIN $63.32
  • CYTK $81.36
  • Technical
  • Relative Strength Index (RSI)
  • MAIN 62.39
  • CYTK 58.40
  • Support Level
  • MAIN $59.34
  • CYTK $45.05
  • Resistance Level
  • MAIN $63.25
  • CYTK $48.30
  • Average True Range (ATR)
  • MAIN 0.91
  • CYTK 2.80
  • MACD
  • MAIN 0.01
  • CYTK 0.61
  • Stochastic Oscillator
  • MAIN 73.46
  • CYTK 86.80

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing's, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: